InvestorsHub Logo
Followers 1
Posts 589
Boards Moderated 0
Alias Born 05/19/2004

Re: None

Thursday, 04/06/2006 9:23:05 AM

Thursday, April 06, 2006 9:23:05 AM

Post# of 292
SSB-T NR today 83m at .65

Stressgen names Rieder to board; Lennox resigns


2006-04-06 08:27 ET - News Release

Ms. Donna Slade reports

Stressgen Biotechnologies Corp. is appointing Robert Rieder, vice-chairman and chief executive officer of Cardiome Pharma Corp., to the board of directors. In addition, Dr. Jay Short, PhD, has been appointed chairman of the board, replacing R. Ian Lennox who is resigning from the board.

"We are extremely pleased with Bob Rieder's appointment to our board of directors," commented Gregory McKee, president and chief executive officer. "We believe his extensive experience in the health care industry and exemplary track record building Cardiome Pharma make him an ideal addition to our board. We are also pleased that Jay Short has agreed to serve as chairman, providing continued scientific and business leadership. We would like to take this opportunity to sincerely thank Ian Lennox for his dedicated service and significant contribution to the company."

Mr. Rieder joined Cardiome in April of 1988 as president and chief executive officer, and was recently appointed as the company's vice-chairman of the board. Mr. Rieder has extensive experience in venture capital and in operational management. Prior to joining Cardiome, he was vice-president at MDS Ventures Pacific Inc., the Vancouver-based affiliate of MDS Capital Corp., and has served as a director for nine public and private technology companies. In his venture capital career, Mr. Rieder led several rounds of financing for Stressgen and was a director of the company from 1992 until 2000. Prior to joining MDS, Mr. Rieder was president and chief executive officer of Synapse Technologies and chief operating officer of DBA Telecom Inc. Mr. Rieder received his BASc (chemical engineering) from the University of British Columbia and his MBA from the University of Western Ontario.

Dr. Short has served on the Stressgen board of directors for 12 years. In 2005, Dr. Short became chairman, president and founder of the E.O. Wilson Biodiversity Foundation in San Diego, Calif. Dr. Short served as president, chief executive officer, chief technology officer, director and founder of Diversa Corp. from September, 1994, to October, 2005.


Just My Humble Opinion
But WTFDIK

OTG

For Real trading Chat use: http://www.tradingchief.com/

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.